Drug Topics April 29, 2024
Drug Topics staff

Check out these important FDA updates from the month of April 2024.

FDA Approves Iloperidone for Acute Treatment of Manic, Mixed Episodes in Bipolar I

The FDA approved iloperidone tablets (Fanapt) for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. The atypical antipsychotic agent was initially approved in 2009 for the acute treatment of schizophrenia. loperidone includes a boxed warning for increased mortality in older patients with dementia-related psychosis.

FDA Approves Antibiotic Ceftobiprole Medocaril for Injection for 3 Indications

The FDA approved antibiotic ceftobiprole medocaril sodium for injection (Zevtera) for 3 indications: the treatment of adults with Staphylococcus aureus bacteremia (SAB), including right-sided infective endocarditis; the treatment of adults with acute bacterial skin...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies
Related Articles:
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article